This protocol is judged by an institutional evaluation board, an impartial group that reviews any scientific trials involving humans. If a research will involve a Timetable I drug, after the board approves the protocol as ethical, the researchers must apply for an investigational new drug (IND) variety with the FDA.Luckily, other corporations with